HERA soll eine Rolle ähnlich der der US Biomedical Advanced Research and Development Authority (BARDA) spielen, die entscheidend zur beispiellos schnellen Entwicklung der Impfstoffe von Oxford-AstraZeneca, Moderna und Johnson & Johnson beigetragen hat.
HERA is intended to play a role similar to that of the US Biomedical Advanced Research and Development Authority (BARDA), which has been instrumental in the unprecedentedly rapid development of the Oxford-AstraZeneca, Moderna, and Johnson & Johnson vaccines.